Results 151 to 160 of about 33,583 (261)

A nomogram for risk prediction in patients with heart failure and diabetes: Development and validation. [PDF]

Medicine (Baltimore)
Zhang Z, Li D, Zhao J, Ma H, Wang F, Hao Q.   +5 more
europepmc   +1 more source

Early Risk Identification of Sepsis During Induction Chemotherapy in Newly Diagnosed AML: A Nomogram‐Based Tool

Cancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Background Patients with acute myeloid leukemia (AML) experience severe infections frequently during and after chemotherapy. The purpose of this study was to develop an early risk assessment tool to identify newly diagnosed AML patients at high risk of developing sepsis during the early phase of induction chemotherapy.
Cui‐Ying Gu, Ya‐Shu Feng, Qing‐Song He, Ling Zhang, Jia‐Jun Liu   +4 more
wiley   +1 more source

Precision Monitoring Strategies for Chemotherapy-Induced Cardiotoxicity: A Review of Molecular Indicators for Early Detection and Risk Stratification. [PDF]

Rev Cardiovasc Med
Kong Y, He R, He H, Liao L, Wu C, Chen X, Peng X.   +6 more
europepmc   +1 more source

A Rare Constellation of Peripartum Cardiomyopathy Manifesting With Multiple Thromboembolic Phenomena in a 15‐Year‐Old

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT A 15‐year‐old postpartum primipara presented at 19 days with aphasia, right hemiparesis, chest pain, and dyspnea. Diagnostics confirmed concurrent cardioembolic stroke and pulmonary embolism secondary to peripartum cardiomyopathy (ejection fraction 29%).
Reuben E. Mkama, Bibiana Kazaura, Theresia E. Lutufyo, Baraka E. Mrisho, Hery O. Kimwela, Marco E. Nyakasalule, Ronald M. Costantini, Eliya Msemwa, Florence Malamso, George Assenga, Julius Kinyange, Josephine R. Laswai, Fabian M. Kamana, Godfery Malangwa, David S. Mazengo, Raymond Leiya, Andrea S. Hondo, Masuma Gulamhussein, Happiness J. Mathew, Paul P. Mwasapi, Phillip S. Muhochi, Hakolo L. Mgaya, Moa E. Kalunga, Brendan P. Shayo, Amani E. Senso, Leonia N. Ndakamaze, Tuzo Lyuu, Anna A. Sanga, Rosemary P. Minja, Deusdedit Ndilanha, Emmanuel J. Magandi, Nkulikiye Kanani, Anthony J. Gyunda, Immaculate R. Goima, Justus L. Ishengoma, Janet L. Mtenga, Flora N. Ndobho, Kigocha L. Okengo, Paschal N. Kulwijila, Pius C. Njingo   +39 more
wiley   +1 more source

The pulmonary artery hypertension and cancer: PULAHYCA PILOT study. Initial prostanoid therapy in cancer patients with pulmonary hypertension: results from an observational study. [PDF]

Cardiooncology
Gregorietti V, López-Fernández T, Herrmann J, Costa D, Daniele AJ.   +4 more
europepmc   +1 more source

Impact of Severe Postoperative Multi‐Organ Dysfunction on Long‐Term Outcomes After Modified Morrow Surgery

Clinical Cardiology, Volume 49, Issue 8, August 2026.
This retrospective cohort study (n = 380) demonstrates that severe postoperative multi‐organ dysfunction (SOFA Maximum ≥ 11) is a strong independent predictor of long‐term adverse outcomes after modified Morrow surgery. Incorporating the SOFA score into postoperative assessments helps identify high‐risk hypertrophic obstructive cardiomyopathy patients ...
Tong Wang, La Ta, Kui Zhang, Ran Dong, Yu Xiao, Jiayang Wang   +5 more
wiley   +1 more source

Correlation between pharmacologic blood pressure-lowering intensity and improvement in cardiac function in patients with acutely decompensated heart failure. [PDF]

BMC Cardiovasc Disord
Zhang Z, Fan Z, Liu Y, Han L.
europepmc   +1 more source

Superior Cardiorenal Protection With Tirzepatide Over Dulaglutide in Heart Failure With Preserved Ejection Fraction: A Large‐Scale Propensity Score–Matched Real‐World Analysis

Clinical Cardiology, Volume 49, Issue 8, August 2026.
In this large real‐world propensity‐matched analysis, tirzepatide demonstrated superior reductions in mortality, hospitalizations, and cardiorenal outcomes versus dulaglutide in HFpEF patients, with a favorable safety profile. ABSTRACT Background No direct head‐to‐head trials compare tirzepatide and dulaglutide in heart failure with preserved ejection ...
Ibrahim Khalil, Md. Imran Hossain, Mst. Mahmuda Akter, Ferdous Wahid, Aizaz Anwar Khalid, Sunjida Amin Promi, Md. Abu Sayed, Mohd Turzo Rahman, Pallab Sarker   +8 more
wiley   +1 more source

Outcomes of EKOS (Ultrasound-Assisted Thrombolysis) for Intermediate-High-Risk Pulmonary Embolism: A PERT-Guided Cohort Study. [PDF]

Interdiscip Cardiovasc Thorac Surg
Ali MNHE, Zayat R, Hatam N, Greven J, Nies J, Mohammed AFA, Kersten A, Marx N, Dreher M, Shieba Y, Spillner J, Kalverkamp S.   +11 more
europepmc   +1 more source

Lung Pericytes: Molecular Mechanisms, Signaling Pathways, and Roles in Pulmonary Diseases

Comprehensive Physiology, Volume 16, Issue 4, August 2026.
Central role of pericytes across major pulmonary diseases. Conceptual wheel diagram illustrating the central role of lung pericytes across diverse pulmonary disease states. A pericyte positioned at the center expresses canonical markers, including PDGFRβ, CD146, and NG2, and connects radially to five major disease contexts.
Stuti Agarwal, Anuradha Bankar, Vinicio A. de Jesus Perez   +2 more
wiley   +1 more source